Polish Stress Echocardiography Registry (Pol-STRESS Registry) - a multicenter study. Stress echo in Poland : numbers, settings, results and complications
| Autor: | Zbigniew Gąsior, Jolanta Rzucidło-Resil, Barbara Brzezińska, Beata Zaborska, Iwona Świątkiewicz, Szymon Olędzki, Marta Marcinkiewicz-Siemion, Agnieszka Olszanecka, Piotr Gościniak, Andrzej Szyszka, Wojciech Kosmala, Jan Błażejewski, Wojciech Witkiewicz, Jarosław D. Kasprzak, Marcin Fijałkowski, Katarzyna Mizia-Stec, Tomasz Kukulski, Danuta Sorysz, Edyta Płońska-Gościniak, Dariusz A. Kosior |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Coronary Artery Disease 030204 cardiovascular system & hematology Asymptomatic Coronary artery disease 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Stress Echocardiography Humans Registries 030212 general & internal medicine Myocardial infarction Retrospective Studies business.industry valvular heart disease medicine.disease Stenosis Ambulatory Cardiology Dobutamine Poland medicine.symptom Cardiology and Cardiovascular Medicine business Echocardiography Stress medicine.drug |
| Popis: | Background: Stress echocardiography (SE) is widely used in Europe. No collective data have been available on the use of SE in Poland until now. Aim: To evaluate the number of SE investigations performed in Poland, their settings, complications, and results. Methods: In this retrospective survey, referral cardiology centres in Poland were asked to fill in a questionnaire regarding SE examinations performed from May 1, 2014 to May 1, 2015. Results: The study included data from 17 university hospitals and large community hospitals, which performed 4611 SE examinations, including 4408 tests in patients investigated for coronary artery disease (CAD) and 203 tests to evaluate valvular heart disease (VHD). To evaluate CAD, all centres performed dobutamine SE (100%), 10 centres performed pacing SE (58.8%), while cycle ergometer SE and treadmill SE were performed by six (35.3%) and five (29.4%) centres, respectively. Dipyridamole SE was performed in one centre. All evaluated centres (100%) performed SE to evaluate low-flow/low-gradient aortic stenosis, eight (47%) performed SE to evaluate asymptomatic aortic stenosis, and also eight (47%) performed SE to evaluate mitral regurgitation. The mean number of examinations per year was 271 per centre. Most centres performed more than 100 examinations per year (11 centres, 64.7%). We did not identify any cardiac death during SE examination in any of the centres. Myocardial infarction occurred in three (0.07%) patients. Non-sustained ventricular tachycardia occurred in 52 (1.1%) SE examinations. The rates of minor complications were low. SE to evaluate CAD was more commonly performed in the hospital settings using cycle ergometer (72.6%), treadmill (87.6%), and low-dose dobutamine (68.0%), while a dipyridamole test was more frequently employed in ambulatory patients (77.6%). No significant differences between the rates of examinations performed in the ambulatory and hospital settings were found for high-dose dobutamine and pacing SE. Examinations to evaluate VHD were significantly more frequently performed in the hospital settings. SE examinations accounted for more than one third of all stress tests performed in the surveyed centres over the study period. Conclusions: Stress echocardiography is a safe diagnostic method, and major complications are very rare. Despite European recommendations, SE examinations to evaluate CAD are performed less frequently than electrocardiographic exercise tests, although they already comprise a significant proportion of all stress tests. It seems reasonable to promote SE further for the evaluation of both CAD and VHD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|